Catalyst Wire Dossier Catalyst Wire Dossier

Angiotensin-Neprilysin inhibition (unspecified)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Angiotensin-Neprilysin inhibition (unspecified), covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation [Phase 2]

See pricing